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ferent imaging sequences [3, 4]. In addition, 
two recent studies have found an increase in 
FDG uptake in the carotid artery of HIV-positive 
patients without any symptoms of cardiovascu-
lar disease [5, 6]. Since HIV-positive patients 
are known to have an increased risk of athero-
sclerosis, it has been speculated that the 
increase in FDG uptake could be a marker of 
very early atherosclerotic changes (e.g. endo-
thelial dysfunction). Combined MR and PET can 
be expected to have an added value over PET/
CT in non-invasive imaging of atherosclerosis 
[7] since CT in essence does not visualize the 
vessel wall but primarily the lumen. 
Recently, a whole-body PET/MR imager was 
developed that allows simultaneous MR and 
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Abstract: The study aimed at comparing PET/MR to PET/CT for imaging the carotid arteries in patients with known 
increased risk of atherosclerosis. Six HIV-positive men underwent sequential PET/MR and PET/CT of the carotid 
arteries after injection of 400 MBq of 18F-FDG. PET/MR was performed a median of 131 min after injection. Sub-
sequently, PET/CT was performed. Regions of interest (ROI) were drawn slice by slice to include the carotid arteries 
and standardized uptake values (SUV) were calculated from both datasets independently. Quantitative comparison 
of 18F-FDG uptake revealed a high congruence between PET data acquired using the PET/MR system compared to 
the PET/CT system. The mean difference for SUVmean was -0.18 (p < 0.001) and -0.14 for SUVmax (p < 0.001) indicat-
ing a small but significant bias towards lower values using the PET/MR system. The 95% limits of agreement were 
-0.55 to 0.20 for SUVmean and -0.93 to 0.65 for SUVmax. The image quality of the PET/MR allowed for delineation of 
the carotid vessel wall. The correlations between 18F-FDG uptake from ROI including both vessel wall and vessel 
lumen to ROI including only the wall were strong (r = 0.98 for SUVmean and r = 1.00 for SUVmax) indicating that the 
luminal 18F-FDG content had minimal influence on the values. The study shows for the first time that simultaneous 
PET/MR of the carotid arteries is feasible in patients with increased risk of atherosclerosis. Quantification of 18F-FDG 
uptake correlated well between PET/MR and PET/CT despite difference in method of PET attenuation correction, 
reconstruction algorithm, and detector technology.
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Introduction
Atherosclerosis usually remains asymptomatic 
until it has reached an advanced phase. 
Therefore methods for non-invasive identifica-
tion of both early and very advanced athero-
sclerotic plaques are pursued. The use of 18F-
FDG positron emission tomography (PET) or 
magnetic resonance (MR) for imaging athero-
sclerosis has received much attention recently. 
18F-FDG PET has been used as a molecular 
marker of inflammation and thus perhaps vul-
nerability of plaques [1, 2] and MR imaging has 
been proven effective in differentiating plaque 
components based on signal intensities and 
morphological appearance of the plaque on dif-
PET/MR of the carotid artery
362 Am J Nucl Med Mol Imaging 2013;3(4):361-371
PET imaging. The machine (Biograph mMR) 
consists of a 3-Tesla MR scanner that encloses 
an avalanche photodiode–based PET system 
within its gantry. The main advantage of the 
simultaneous isocentric acquisition when imag-
ing atherosclerosis is the perfect alignment 
between PET and MR allowing for a precisede-
lineation of the vessel wall or plaque and char-
acterization of subareas of a plaque (e.g. the 
necrotic core) along with decreased examina-
tion time compared to sequential MR and PET. 
In comparison with PET/CT the advantages are 
decreased radiation and superior soft-tissue 
characterization with MR. However, the quality 
of the acquired PET and MR data may be affect-
ed in a combined PET/MR system. First, the 
attenuation correction of the PET data has to 
be derived from MR information. This is prob-
lematic since MR does not contain direct infor-
mation about the attenuation from the tissue. 
Second, the PET detectors inside the MR scan-
ner cause inhomogeneities in the magnetic 
field and electromagnetic interference, which 
potentially degrade the MR image quality. 
Finally, the replacement of the photomultipliers 
with avalanche photodiodes may affect the 
PET acquisition. 
So far, the quality of clinical PET examinations 
from integrated whole-body PET/MR scanners 
with attenuation correction using MR data 
have only been systematically compared with 
examinations acquired on a PET/CT scanner in 
the same patients in very few trials [8, 9]. These 
studies found the reliability of PET/MR to be 
comparable to that of PET/CT in the detection 
of lesions suspicious for malignancy. Another 
recent phantom experiment did not find any 
perceptible impact on the overall performance 
of the system [10]. Imaging the carotid arteries 
with the PET/MR system has so far never been 
published in humans.
The aim of this study was for the first time to 
evaluate the feasibility of integrated PET/MR 
imaging of the carotid arteries in humans by: 1) 
comparison of the standardized uptake value 
(SUV) in the carotid arteries obtained with inte-
grated PET/MR with SUV from PET/CT in the 
same HIV-positive patients. 2) Comparison of 
SUV obtained when including only the vessel 
Figure 1. Flow chart of the study.
PET/MR of the carotid artery
363 Am J Nucl Med Mol Imaging 2013;3(4):361-371
wall in the region of interest (ROI), with the tra-
ditional approach of including both vessel wall 
and lumen in the ROI. 
Materials and methods
Study design
Six HIV-positive patients were prospectively 
recruited at routine visits at our outpatient clin-
ic. Inclusion criteria were i) HIV infected, ii) age 
18-70 years and iii) receiving cART > 12 
months.
Exclusion criteria were symptoms of cardiovas-
cular disease, age < 18 years, diabetes, preg-
nancy, renal insufficiency, treatment with cho-
lesterol lowering drugs, or severe 
claustrophobia.
All patients underwent a single-injection dual-
imaging protocol of simultaneous PET/MR and 
subsequent integrated PET/CT on the same 
day. PET/MR and PET/CT was performed with 
less than 1 hour (range 35 to 49 minutes) 
between the two PET acquisitions using the 
same 18F-FDG injection. On the same day 
(before tracer injection) real-time intima media 
thickness was measured in the common carot-
id artery 1 cm caudal of the bulbus arteriosus 
(RF-QIMT, Esaote, Italy). An outline of the study 
design is shown in Figure 1.
Patients fasted at least 6 hours prior to injec-
tion of 400 MBq 18F-FDG (range 397-405) in a 
cubital vein catheter. Plasma glucose mea-
sured before injection ranged from 4.0 to 6.0 
mmol/l. To reduce tracer uptake in neck and 
mouth musculature the patients were not 
allowed to talk and to avoid uptake in brown fat 
they rested in calm and warm surroundings 
from 15 min before injection until 30 min after 
injection. 
Ethical approval
The study was approved by the Regional 
Scientific Ethical Committee (protocol H-4-
2010-044) and all subjects received oral and 
written information about the study and signed 
an informed consent before inclusion.
PET/MR acquisition
Simultaneous PET/MR was performed on the 
Biograph mMR (Siemens Healtcare) using a 
dedicated head and neck coil (Siemens 
Healthcare). Patients were fixed in the scanner 
and imaging started a median of 131 minutes 
after 18F-FDG injection. Scout images were 
obtained for localization of the carotid arteries. 
An mMR standard Dixon water-fat MR sequence 
was then recorded and segmented (into air, 
lung tissue, soft tissue and fat) for MR-based 
PET attenuation correction (MR-AC) [11]. A 3D 
time-of-flight (TOF) bright magnetic resonance 
angiography sequence was then performed to 
obtain lumen contours. MR parameters for 
3D-TOF were: TR/TE 21/3.6 ms, flip angle 12°.
Next, a stack of 14 axial 2D turbo spin echo 
dark blood images with fat suppression of the 
common carotid arteries in proton density, T1 
and T2 weightings with slice thickness of 2 mm 
and matrix size of 256 were centered using the 
3D-TOF angiography. Images were centered 
with 4 slices cranial to the bifurcation on the 
right side, and 10 slices caudal to the bifurca-
tion. MR parameters were: T1-weighted: double 
inversion recovery, TR/TE = 1060/26 ms, echo 
train length = 7. T2-weighted: TR/TE = 2500/76 
ms, echo train length = 15. Proton density-
weighted: TR/TE = 2400/16 ms, echo train 
length = 15.
PET acquisition was started simultaneously 
with the start of the Dixon MR sequence using 
the same bed position. Acquisition time was 10 
min in three-dimensional list mode. The total 
average examination time was below 30 
minutes.
PET/CT acquisition
Three hours after 18F-FDG injection (range 166 
to 181 minutes), the patient was scanned using 
a combined PET/CT-scanner (Siemens Biograph 
mCT64, Siemens, Berlin, Germany). PET was 
acquired in three-dimensional list mode for 3 
min over one field of view centered at the carot-
id bifurcation. Two CT examinations were per-
formed in each patient; one CT scan (120 kV, 
reference mAs 225 (care dose)) for attenuation 
correction preceded the PET acquisition and 
one contrast enhanced CT scan (120 kV, refer-
ence mAs 225 (care dose)) was performed just 
after the PET acquisition. Contrast was injected 
by pump (100 ml of Optiray 300 mg/ml at 2.5 
ml/s followed by 100 ml of saline at 2.5 ml/s) 
and the CT was automatically initiated after a 
delay of 10 s when a cutoff of 80 Hounsfield 
units was reached in the descending aorta.
PET/MR of the carotid artery
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PET/CT: A routinely used, optimized clinical 
reconstruction setting using CT based attenua-
tion correction [1] was used on the PET from 
the PET/CT, using both resolution-recovery 
(point spread function, TrueX) and time-of-flight 
(2 iterations, 21 subsets, zoom 1.0 ) giving 400 
x 400 image slices (voxel size 2.04 x 2.04 x 
2.00). A 2 mm full width at half maximum 
Gaussian filter was the applied to all images 
post-reconstruction.
Data analysis
Anatomical co-registration of CT and MR was 
done by automatic rigid registration and subse-
quent visual confirmation of anatomical land-
marks like the carotid bifurcation and the verte-
bral arteries. The carotid artery was analyzed 
slice by slice in every subject in the PET/CT 
Image reconstruction
All patients had 2 PET datasets of the carotid 
artery; “PET/MR” from the PET/MR system with 
parameters optimized for the PET/MR system 
and “PET/CT” from the PET/CT system recon-
structed with parameters optimized for the 
PET/CT system. The PET from the PET/MR scan 
was reconstructed using ordered-subsets 
expectation maximization iterative reconstruc-
tion algorithm (OSEM 3D) (6 iterations, 21 sub-
sets, zoom 2.0) with MR based attenuation cor-
rection yielding 512 x 512 image slices (voxel 
size: 0.70 x 0.70 x 2.03 mm). Attenuation maps 
for correction of the PET data from the PET/MR 
scanner were generated on the basis of the 
Dixon water-fat MR sequence [11]. This proce-
dure operates automatically in the postpro-
cessing software of the scanner.
Figure 2. MR and fused FDG-PET/MR. Example of transverse MR and fused FDG-PET/MR (same patient and slice 
position as Figure 3) at a level with the right common carotid artery (red arrow) and the left internal carotid artery 
(white arrow). A ROI including both the vessel wall and lumen is drawn in column A, and a ROI including only the 
vessel wall is drawn in column B.
PET/MR of the carotid artery
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dataset and the PET/MR dataset independent-
ly. Dataset “PET/MR” was fused with the simul-
taneously acquired MR images (T1, T2, and 
proton density weighted). A free-hand ROI was 
drawn around the common carotid artery and 
the internal carotid artery slice by slice on the 
axial MR images including both the vessel wall 
and the vessel lumen (Figure 2A). All three MR 
weighted images were used in defining the ves-
sel. SUVmean and SUVmax that correct for injected 
dose, patient weight and time to acquisition 
were calculated for each ROI. Subsequently a 
similar approach was used on datasets “PET/
CT” using only the contrast enhanced CT to 
identify the carotid artery and not the MR imag-
es (Figure 3).
Finally, new free-hand ROIs were drawn on the 
axial MR images including only the vessel wall 
and excluding the vessel lumen (Figure 2B). 
Again SUVmean and SUVmax from these ROIs were 
calculated from dataset “PET/MR” on a slice by 
slice basis. 
Figure 3. CT and fused FDG-PET/CT. Example of 
transverse CT and fused FDG-PET/CT from the same 
patient and slice position as Figure 2. The right com-
mon carotid artery is marked by a red arrow on the 
left internal carotid artery is marked by a white ar-
row. A ROI including both the vessel wall and lumen 
is drawn.
In summary, the data analysis resulted in 3 
SUVmean and 3 SUVmax calculations per slice, as 
well as 3 SUVmean and 3 SUVmax calculations per 
artery (right/left). 
Statistical analysis
SUV calculated from the PET/MR was com-
pared with SUV calculated from the PET/CT 
using the method of Bland and Altman [12]. 
According to this method, the mean difference 
between measurements is defined as “bias” 
and represents the systemic error in measure-
ments. The statistical significance of the bias 
was assessed using the t-test. The 95% limits 
of agreement were defined as mean difference 
± 1.96 times the standard deviation. All limits 
of agreement were calculated assuming nor-
mal distribution of the differences. The agree-
ment was further assessed using the Pearson r 
correlation coefficient. Comparisons were done 
both slice by slice (168 comparisons) and 
artery by artery (12 comparisons). Paired com-
parison of ROIs including or excluding the ves-
sel lumen from SUV calculations were per-
formed with the t-test. Analyses were performed 
with IBM SPSS Statistics (version 20, IBM).
Results
Patient characteristics are shown in Table 1. All 
patients were HIV-positive men on stable anti-
viral therapy. No patients had symptoms of car-
diovascular disease, but one patient had an 
asymptomatic, stable aortic aneurism. The 
patients had only few classic cardiovascular 
risk factors. None of the patients had hemody-
namic significant stenoses of the carotid arter-
ies by the ultrasound. PET/MR and PET/CT 
examinations were feasible in all patients and 
all slices were analyzable. Figure 4 shows an 
example of the four image sequences used for 
the MR examination with high luminal and 
external contrast of the carotid artery which are 
shown with arrows.
Quantitative comparison between PET obtain- 
ed in the PET/MR scanner and in the PET/CT 
scanner
A total of 168 carotid vessel segments were 
analyzed with 14 axial slices per vessel.
SUVmean and SUVmax were calculated from ROIs 
drawn independently using the PET/CT dataset 
only (Figure 3) or the PET/MR dataset only 
PET/MR of the carotid artery
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including only the vessel wall from the simulta-
neous PET/MR examination (Figures 2 and 7). 
A total of 162 of the 168 slices (96%) had a 
perfect match (difference of 0.0) of SUVmax and 
125 (74%) had a perfect match of SUVmean. The 
mean increase in SUVmean when excluding the 
vessel lumen compared to including the lumen 
in the ROI was 1.0% (p = 0.002) with a 95% 
confidence interval from 0.3% to 1.6%. In com-
parison, the mean increase in SUVmax was only 
0.3% (p = 0.02) with 95% confidence interval 
from 0.04 to 0.5%.
Discussion
In this study of HIV patients with increased risk 
of atherosclerosis but without any symptoms of 
cardiovascular disease, we present the first 
results from simultaneous PET/MR of the carot-
id arteries. We found a high congruence 
between PET data acquired using PET/MR to 
identify the carotid artery and PET data 
acquired using traditional PET/CT to identify 
dent of the SUV magnitude. Also, the cor-
relation between the two systems were 
moderate with the best correlation in the 
vessel by vessel comparisons for both 
SUVmean (Figure 5D) and SUVmax (Figure 
6D).
Comparison SUV with and without lumen
The luminal contributions to SUVmean and 
SUVmax were minimal as shown by the 
almost perfect correlation between val-
ues obtained from an ROI including both 
vessel wall and lumen compared to 
(Figure 2A). The SUVmax ranged from 0.9 to 2.7 
in the PET/MR system and from 1.1 to 3.2 in 
PET/CT system. The SUVmean ranged from 0.5 to 
1.8 and 0.8 to 2.1 in the PET/MR and PET/CT 
systems, respectively.
Values obtained by the two systems (PET/MR 
and PET/CT) were very similar (Figures 5 and 6) 
with a small but statistical significant bias 
(mean difference) of less than -0.2 (p < 0.001 
for both SUVmean and SUVmax). The bias was 
towards SUV from the PET/MR system being 
slightly lower than values from the PET/CT sys-
tem. No extreme or outlying observations were 
found. The 95% limits of agreement were -0.6 
to 0.2 for SUVmean and -0.9 to 0.7 for SUVmax 
using the slice by slice comparison and -0.4 to 
0.1 for SUVmean and -0.6 to 0.4 for SUVmax using 
the vessel by vessel comparison. The correla-
tions between the two systems were similarly 
high (Figures 5 and 6). The Bland-Altman plots 
of difference indicate that the variability of the 
difference between the systems is indepen-
Figure 4. Example of 4 MR imaging sequences from identical location in the same patient. Images are T1 weighted 
(T1w), T2 weighted (T2w), Time of flight angiography (TOF angio) and proton density weighted (PDw). The vessel wall 
of the right common carotid artery (red arrow) and the left internal carotid artery (white arrow) appear hyperintense 
on T1w, T2w, and PDw images.
Table 1. Characteristics of the 6 included patients
N
Male gender 6 (100%)
Age (median, range) 42 (29-66)
BMI (median, range) 25 (22-28)
Family history of ischemic heart disease 0
Smoking (current/ex/never) 0/1/0
Known hypertension 1 (17%)
Diabetes 0
Known cardiovascular disease 1 (17%)
Intima media thickness, μm (median, range) 672 (553-956)
PET/MR of the carotid artery
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process of anatomical alignment between MR 
and PET when acquired on separate stand-
alone systems. In addition, it is very difficult to 
place the patient at the same position in the 
scanner with identical angulation of the neck 
required for perfect anatomical co-localization 
of the PET and the MR examination. The intro-
duction of the hybrid PET/MR system over-
comes these limitations and is thus a very suit-
able method for carotid artery imaging. 
However, the hybrid PET/MR system has other 
potential problems that need to be addressed. 
First, attenuation correction of the PET data is 
essential to gain accurate measurements. In 
PET/CT scanners, attenuation correction is 
the carotid artery indicating feasibility of simul-
taneous PET/MR for studies of the carotid 
arteries. Additionally, we found evidence that 
MR can be used to delineate both the inner 
and outer wall of the carotid artery and thus 
the possibility for a more specific ROI to calcu-
late SUV from the fused PET acquisition. 
Despite the obvious potential for synergy 
between PET and MR imaging in atherosclero-
sis, only a few human studies have applied 
these two modalities [7, 13, 14] and none have 
included patients with only mild atherosclero-
sis/endothelial dysfunction. This is probably at 
least in part caused by the very cumbersome 
Figure 5. SUVmean comparison between the PET/CT dataset and the PET/MR dataset. Slice by slice (n = 168, A and 
B) and vessel by vessel (n = 12, C and D). Panel A and C show the Bland-Altman plots of difference with identity line 
shown in black and the mean difference with 95% limits of agreement shown in horizontal red lines. Panel B and D 
show the correlation with a dashed black identity line.
PET/MR of the carotid artery
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an attenuation map based on the presumed 
density of these tissue types. The obtained 
attenuation maps are without bone which can 
seriously affect the quantification of the PET 
images [16, 17]. Methods that in different ways 
include bones in MR-based attenuation maps 
are being developed [18-20] but are not yet 
available in any of the systems for clinical use. 
The impact of using Dixon MR-based attenua-
tion correction with missing bones is estimated 
to give only a 4 ± 2% (mean ± SD) error on neck 
lesions [11] but no large scale studies or inves-
tigations specific to the neck region have been 
based on an accurate attenuation map gener-
ated from a CT transmission scan.
In MR, the image formation is based on nuclear 
magnetic resonance of the tissue which cannot 
directly be used for attenuation correction. 
Both available whole-body integrated PET/MR 
systems (Siemens mMR [10] and Philips 
Ingenuity TF [15]) uses segmentation of dedi-
cated MR images for attenuation correction 
[11]. The estimated distribution of air, lungs, 
fat, and soft tissue (Siemens mMR) or air, lungs, 
and soft tissue (Philips Ingenuity TF) generates 
Figure 6. SUVmax comparison between the PET/CT dataset and the PET/MR dataset. Slice by slice (n = 168, A and 
B) and vessel by vessel (n = 12, C and D). Panel A and C show the Bland-Altman plots of difference with identity line 
shown in black and the mean difference with 95% limits of agreement shown in horizontal red lines. Panel B and D 
show the correlation with a dashed black identity line.
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are needed to determine any extra diagnostic 
information in the PET from the PET/MR com-
pared to the PET from the PET/CT. 
Methodological differences could also explain 
the difference in the SUVs observed. First, PET/
MR and PET/CT were acquired with approxi-
mately 1 hour difference, however based on 
our previous comparison of SUVmax in the carot-
id artery after 1 hour and 3 hours, we find it 
unlikely that this time difference would have 
substantial effect on the results [21]. Second, 
the two PET scanners differ in both hardware 
(detector technology, geometry, presence of 
MR coils) and software (method of attenuation 
correction, time of flight, resolution-recovery) 
resulting in multiple reasons for variation in 
SUV as previously described [22].
The use of simultaneous PET/MR allow for pre-
cise delineation of both the inner and outer 
carotid vessel wall using the different weighted 
MR images. This could potentially lead to a 
more specific assessment of FDG accumula-
tion in the vessel wall as compared to the con-
ventional ROI including both vessel wall and 
lumen especially in patient without large ath-
erosclerotic lesions. In our study, we found an 
almost perfect correlation between SUVmax cal-
culated from the ROI including both vessel wall 
done. Our data support the hypothesis, that 
MR based attenuation correction of the carotid 
arteries are feasible since we find only a small 
mean difference (bias) and a strong correlation 
between SUV from the PET/MR system com-
pared to SUV from the PET/CT system in the 
same patients. This further supports the recent 
findings of only small, but significant difference 
between SUVmean in a number of organs in 32 
patients with oncologic disease undergoing 
both PET/CT and subsequent simultaneous 
PET/MR [8]. 
The hypothesis of our trial was that we would 
find differences in SUV between the two sys-
tems since the ROIs including the carotid arter-
ies would differ when using the CT or the MR 
images to delineate the vessel wall. It is clear 
from Figure 4 that MR allows for superior delin-
eation of especially the outer edge of the ves-
sel as compared to the CT and it was our 
hypothesis that the PET/MR would give a more 
accurate calculation of the 18F-FDG accumula-
tion in the vessel wall than the PET/CT. Thus, 
even though the limits of agreement between 
the systems in our study are narrow, they could 
be of importance. Future studies comparing 
the two PET acquisitions to other measures of 
vessel inflammation or endothelial dysfunction 
such as histology or gene expression analysis 
Figure 7. Correlation between SUV. SUV calculated from ROIs including only the vessel wall (Figure 2A) compared to 
ROIs including both vessel wall and vessel lumen (Figure  2B) using the same PET/MR images.
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Conclusion
In this first clinical study of simultaneous PET/
MR for carotid artery imaging we found the 
method feasible in patients without large ath-
erosclerotic plaques. Compared with PET/CT it 
yields comparable 18F-FDG quantification and 
superior delineation of the vessel wall. Our 
study suggests that simultaneous PET/MR 
imaging of atherosclerosis should be studied 
further, especially in combination with function-
al MR imaging techniques.
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